Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-01-03 @ 6:48 PM
Study NCT ID:
NCT03648333
Status:
COMPLETED
Last Update Posted:
2018-08-27
First Post:
2018-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)
Sponsor:
Hanlim Pharm. Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-02
First Submit QC Date:
None
Study First Post Date:
2018-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-24
Last Update Post Date:
2018-08-27
Last Update Post Date Type:
ACTUAL